Log in to save to my catalogue

Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-...

Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2754048811

Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms

About this item

Full title

Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2023-02, Vol.37 (2), p.298-307

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Contemporary data on infections after intensive chemotherapy for acute myeloid leukemia (AML) are scarce. Cladribine, high-dose cytarabine, G-CSF, and dose-escalated mitoxantrone (“CLAG-M”) may result in higher remission rates than standard-dose cytarabine plus anthracycline (“7 + 3”) but may result in more infections. We compared moderate to sever...

Alternative Titles

Full title

Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2754048811

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2754048811

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/s41375-022-01786-9

How to access this item